NASDAQ:TLRY • US88688T2096
The current stock price of TLRY is 7.55 USD. In the past month the price decreased by -16.57%. In the past year, price increased by 2.72%.
ChartMill assigns a fundamental rating of 2 / 10 to TLRY. TLRY may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -14.37. The EPS decreased by -379% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.42% | ||
| ROE | -133.4% | ||
| Debt/Equity | 0.18 |
17 analysts have analysed TLRY and the average price target is 12.64 USD. This implies a price increase of 67.45% is expected in the next year compared to the current price of 7.55.
For the next year, analysts expect an EPS growth of 96.56% and a revenue growth 3.75% for TLRY
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.54 | 954.38B | ||
| JNJ | JOHNSON & JOHNSON | 21.1 | 584.231B | ||
| MRK | MERCK & CO. INC. | 22.88 | 303.452B | ||
| PFE | PFIZER INC | 9.01 | 151.524B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10.07 | 123.489B | ||
| ZTS | ZOETIS INC | 18.32 | 56.752B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.77 | 26.045B | ||
| VTRS | VIATRIS INC | 6.31 | 18.336B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.67 | 12.412B | ||
| AXSM | AXSOME THERAPEUTICS INC | 213.39 | 9.261B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
TILRAY BRANDS INC
265 Talbot Street West
Leamington ONTARIO V9X 1J2 CA
CEO: Irwin D. Simon
Employees: 2842
Phone: 13026365400
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
The current stock price of TLRY is 7.55 USD. The price decreased by -2.58% in the last trading session.
TLRY does not pay a dividend.
TLRY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
17 analysts have analysed TLRY and the average price target is 12.64 USD. This implies a price increase of 67.45% is expected in the next year compared to the current price of 7.55.
TILRAY BRANDS INC (TLRY) operates in the Health Care sector and the Pharmaceuticals industry.